SHY Therapeutics
PrivateLast Round
Grant
Jan 6, 2025
Total Funding Raised
$300,616
Company Overview
SHY Therapeutics is a biotechnology company that develops small molecule therapeutics targeting ATPases and GTPases for the treatment of cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SHY Therapeutics Comparables
Compare SHY Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Up Therapeutics | 85% | |
| Kestrel Therapeutics | 80% | |
| QLi5 Therapeutics GmbH | 80% |
SHY Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 6, 2025 | ||||
| Accelerator | Nov 10, 2015 |
SHY Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2025
Monthly visitors increased 1730% MoM, from 30 to 549.
- May 2, 2025
Monthly visitors grew 705% MoM.
SHY Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SHY Therapeutics's valuation, stock price, and market status.
Is SHY Therapeutics a public or private company?
SHY Therapeutics is a private company.
What is the current stock price of SHY Therapeutics?
SHY Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is SHY Therapeutics worth (valuation)?
Valuation information for SHY Therapeutics is not publicly available.
Can I buy SHY Therapeutics stock?
SHY Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SHY Therapeutics's last funding round?
SHY Therapeutics's most recent funding round was Grant on January 6, 2025.
Who are the main investors in SHY Therapeutics?
Key investors in SHY Therapeutics include National Institute of Allergy and Infectious Diseases.
Will SHY Therapeutics IPO soon?
No public IPO plans have been announced for SHY Therapeutics.
How can I track SHY Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SHY Therapeutics's secondary market activity and sign up for updates.